Literature DB >> 23921535

Quantitative multiplex PCR of short fluorescent fragments for the detection of large intragenic POLG rearrangements in a large French cohort.

Cécile Rouzier1, Annabelle Chaussenot2, Valérie Serre3, Konstantina Fragaki1, Sylvie Bannwarth1, Samira Ait-El-Mkadem1, Shahram Attarian4, Elsa Kaphan4, Aline Cano5, Emilien Delmont6, Sabrina Sacconi6, Bénédicte Mousson de Camaret7, Marlène Rio8, Anne-Sophie Lebre8, Claude Jardel9, Romain Deschamps10, Christian Richelme11, Jean Pouget4, Brigitte Chabrol5, Véronique Paquis-Flucklinger1.   

Abstract

Polymerase gamma (POLG) is the gene most commonly involved in mitochondrial disorders with mitochondrial DNA instability and causes a wide range of diseases with recessive or dominant transmission. More than 170 mutations have been reported. Most of them are missense mutations, although nonsense mutations, splice-site mutations, small deletions and insertions have also been identified. However, to date, only one large-scale rearrangement has been described in a child with Alpers syndrome. Below, we report a large cohort of 160 patients with clinical, molecular and/or biochemical presentation suggestive of POLG deficiency. Using sequencing, we identified POLG variants in 22 patients (18 kindreds) including five novel pathogenic mutations. Two patients with novel mutations had unusual clinical presentation: the first exhibited an isolated ataxic neuropathy and the second was a child who presented with endocrine signs. We completed the sequencing step by quantitative multiplex PCR of short fluorescent fragments (QMPSF) analysis in 37 patients with either only one POLG heterozygous variant or a family history suggesting a dominant transmission. We identified a large intragenic deletion encompassing part of intron 21 and exon 22 of POLG in a child with refractory epilepsia partialis continua. In conclusion, we describe the first large French cohort of patients with POLG mutations, expanding the wide clinical and molecular spectrum observed in POLG disease. We confirm that large deletions in the POLG gene are rare events and we highlight the importance of QMPSF in patients with a single heterozygous POLG mutation, particularly in severe infantile phenotypes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23921535      PMCID: PMC3953900          DOI: 10.1038/ejhg.2013.171

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  34 in total

1.  Simple detection of genomic microdeletions and microduplications using QMPSF in patients with idiopathic mental retardation.

Authors:  Pascale Saugier-Veber; Alice Goldenberg; Valérie Drouin-Garraud; Céline de La Rochebrochard; Valérie Layet; Nathalie Drouot; Nathalie Le Meur; Brigitte Gilbert-Du-Ssardier; Géraldine Joly-Hélas; Hélène Moirot; Annick Rossi; Mario Tosi; Thierry Frébourg
Journal:  Eur J Hum Genet       Date:  2006-06-14       Impact factor: 4.246

2.  A novel POLG gene mutation in 4 children with Alpers-like hepatocerebral syndromes.

Authors:  Bulent Kurt; Jaak Jaeken; Johan Van Hove; Lieven Lagae; Ann Löfgren; David B Everman; Parul Jayakar; Ali Naini; Klaas J Wierenga; Gert Van Goethem; William C Copeland; Salvatore DiMauro
Journal:  Arch Neurol       Date:  2010-02

3.  Fatal neonatal-onset mitochondrial respiratory chain disease with T cell immunodeficiency.

Authors:  Janine Reichenbach; Ralf Schubert; Rita Horvàth; Jens Petersen; Nancy Fütterer; Elisabeth Malle; Andreas Stumpf; Boris R Gebhardt; Ulrike Koehl; Burkhart Schraven; Stefan Zielen
Journal:  Pediatr Res       Date:  2006-07-20       Impact factor: 3.756

4.  Structural insight into processive human mitochondrial DNA synthesis and disease-related polymerase mutations.

Authors:  Young-Sam Lee; W Dexter Kennedy; Y Whitney Yin
Journal:  Cell       Date:  2009-10-16       Impact factor: 41.582

5.  The unfolding clinical spectrum of POLG mutations.

Authors:  M J Blok; B J van den Bosch; E Jongen; A Hendrickx; C E de Die-Smulders; J E Hoogendijk; E Brusse; M de Visser; B T Poll-The; J Bierau; I F de Coo; H J Smeets
Journal:  J Med Genet       Date:  2009-07-02       Impact factor: 6.318

6.  Molecular and clinical genetics of mitochondrial diseases due to POLG mutations.

Authors:  Lee-Jun C Wong; Robert K Naviaux; Nicola Brunetti-Pierri; Qing Zhang; Eric S Schmitt; Cavatina Truong; Margherita Milone; Bruce H Cohen; Beverly Wical; Jaya Ganesh; Alice A Basinger; Barbara K Burton; Kathryn Swoboda; Donald L Gilbert; Adeline Vanderver; Russell P Saneto; Bruno Maranda; Georgianne Arnold; Jose E Abdenur; Paula J Waters; William C Copeland
Journal:  Hum Mutat       Date:  2008-09       Impact factor: 4.878

7.  Rare autosomal dominant POLG1 mutation in a family with metabolic strokes, posterior column spinal degeneration, and multi-endocrine disease.

Authors:  Sarah E Hopkins; Arthur Somoza; Donald L Gilbert
Journal:  J Child Neurol       Date:  2009-10-08       Impact factor: 1.987

Review 8.  Gene dosage methods as diagnostic tools for the identification of chromosome abnormalities.

Authors:  L Gouas; C Goumy; L Véronèse; A Tchirkov; P Vago
Journal:  Pathol Biol (Paris)       Date:  2008-06-02

9.  Analysis of mutant DNA polymerase gamma in patients with mitochondrial DNA depletion.

Authors:  Jan-Willem Taanman; Shamima Rahman; Alistair T Pagnamenta; Andrew A M Morris; Maria Bitner-Glindzicz; Nicole I Wolf; James V Leonard; Peter T Clayton; Anthony H V Schapira
Journal:  Hum Mutat       Date:  2009-02       Impact factor: 4.878

10.  POLG1 mutations manifesting as autosomal recessive axonal Charcot-Marie-Tooth disease.

Authors:  Timothy Harrower; Joanna D Stewart; Gavin Hudson; Henry Houlden; Graham Warner; Dominic G O'Donovan; Leslie J Findlay; Robert W Taylor; Rajith De Silva; Patrick F Chinnery
Journal:  Arch Neurol       Date:  2008-01
View more
  8 in total

1.  Synergistic Effects of the in cis T251I and P587L Mitochondrial DNA Polymerase γ Disease Mutations.

Authors:  Karen L DeBalsi; Matthew J Longley; Kirsten E Hoff; William C Copeland
Journal:  J Biol Chem       Date:  2017-02-02       Impact factor: 5.157

2.  Structural basis for processivity and antiviral drug toxicity in human mitochondrial DNA replicase.

Authors:  Michal R Szymanski; Vladmir B Kuznetsov; Christie Shumate; Qingchao Meng; Young-Sam Lee; Gayatri Patel; Smita Patel; Y Whitney Yin
Journal:  EMBO J       Date:  2015-06-08       Impact factor: 11.598

3.  Pure Progressive Ataxia and Palatal Tremor (PAPT) Associated with a New Polymerase Gamma (POLG) Mutation.

Authors:  Nicolas Nicastro; Emmanuelle Ranza; Stylianos E Antonarakis; Judit Horvath
Journal:  Cerebellum       Date:  2016-12       Impact factor: 3.847

4.  Rod bipolar cell dysfunction in POLG retinopathy.

Authors:  Kit Green Sanderson; Eoghan Millar; Anupreet Tumber; Regan Klatt; Neal Sondheimer; Ajoy Vincent
Journal:  Doc Ophthalmol       Date:  2020-06-21       Impact factor: 2.379

5.  Contribution of nuclear and mitochondrial gene mutations in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome.

Authors:  Sanjiban Chakrabarty; Periyasamy Govindaraj; Bindu Parayil Sankaran; Madhu Nagappa; Shama Prasada Kabekkodu; Pradyumna Jayaram; Sandeep Mallya; Sekar Deepha; J N Jessiena Ponmalar; Hanumanthapura R Arivinda; Angamuthu Kanikannan Meena; Rajan Kumar Jha; Sanjib Sinha; Narayanappa Gayathri; Arun B Taly; Kumarasamy Thangaraj; Kapaettu Satyamoorthy
Journal:  J Neurol       Date:  2021-01-23       Impact factor: 4.849

6.  Pathogenicity in POLG syndromes: DNA polymerase gamma pathogenicity prediction server and database.

Authors:  Anssi Nurminen; Gregory A Farnum; Laurie S Kaguni
Journal:  BBA Clin       Date:  2017-04-18

Review 7.  The Intestinal Microbiota May Be a Potential Theranostic Tool for Personalized Medicine.

Authors:  Marina Di Domenico; Andrea Ballini; Mariarosaria Boccellino; Salvatore Scacco; Roberto Lovero; Ioannis Alexandros Charitos; Luigi Santacroce
Journal:  J Pers Med       Date:  2022-03-24

8.  Novel biallelic mutations in POLG gene: large deletion and missense variant associated with PEO.

Authors:  Kunqian Ji; Chuanzhu Yan; Yan Lin; Jixiang Du; Wei Wang; Hong Ren; Dandan Zhao; Fuchen Liu; Pengfei Lin; Yuying Zhao
Journal:  Neurol Sci       Date:  2021-06-29       Impact factor: 3.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.